Neuromodulation and Biomarkers in Neurodegenerative Diseases
A special issue of Cells (ISSN 2073-4409).
Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 1551
Special Issue Editors
Interests: regenerative medicine; astrocyte reactivity; neuron-glia communication; 3D culture systems; focused ultrasound; Parkinson's disease
Interests: neuromodulation; social cognition; empathy and theory of mind; mental illness (e.g., schizophrenia/psychosis, depression); stress and lifestyle
Interests: health biotechnology; analytical chromatography; quantification of biomolecules; antimicrobial resistance
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Recent advances in modulatory and diagnostic technology have introduced enabling tools in pre- and clinical approaches, presenting promising outcomes in neurodegenerative diseases of the central nervous system. However, neurodegenerative diseases such as Parkinson’s and Alzheimer's have a range of molecular and cellular alterations, namely protein accumulation, mitochondrial dysfunction, glutamate excitotoxicity, calcium load, proteolytic stress, oxidative stress, neuroinflammation, and aging, contributing to neuronal damage. Consequently, patients develop motor and non-motor deficits, complicating the management procedures and their quality of life.
Neuromodulation technological approaches have emerged over the last decade as a potential method to mitigate these deficits, enhancing neuroplasticity or acting as a neurorehabilitative tool. Additionally, recent clinical prospects have claimed that non-invasive neuromodulation strategies can be used to diagnose and manage neurodegenerative diseases. Therefore, in this issue, a particular focus will be given to neuromodulation strategies as a treatment and how they can promote physiological changes to the diagnosis or establishment of biomarkers for neurodegenerative diseases.
Thus, the current Special Issue will accept original studies and reviews focusing on neuromodulation, precision medicine, -omics, and biomarkers by cellular/molecular diagnostics.
Dr. Fábio Teixeira
Dr. Nuno Barbosa Rocha
Dr. Mónica Vieira
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
